— Know what they know.
Not Investment Advice
Also trades as: FDC.BO (BSE) · $vol 0M

FDC.NS NSE

FDC Limited
1W: -2.3% 1M: -0.9% 3M: -4.2% YTD: -8.0% 1Y: -10.2% 3Y: +42.2% 5Y: +27.9%
₹372.00 ($3.89)
+9.60 (+2.65%)
 
Weekly Expected Move ±2.9%
₹348 ₹358 ₹369 ₹380 ₹390
NSE · Healthcare · Drug Manufacturers - Specialty & Generic · Alpha Radar Neutral · Power 54 · ₹60.8B mcap · 49M float · 0.201% daily turnover
Smart Money Score
No convergence signal
Key Statistics
Market Cap₹60.8B ($635.1M)
52W Range312.95-527.8
Volume370,941
Avg Volume98,318
Beta0.15
Dividend₹5.00
Analyst Ratings
No analyst coverage
Company Info
CEOAmeya Ashok Chandavarkar
Employees6,659
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2002-07-01
C/3, Skyvistas
Mumbai 400053
IN
91 22 2673 9100
About FDC Limited

FDC Limited manufactures and markets pharmaceutical products in India and internationally. The company offers specialized formulations for various therapeutic segments, including anti-infective, gastrointestinal, ophthalmological, vitamins/minerals/dietary supplements, cardiac, anti-diabetes, respiratory, gynecology, dermatology, analgesics, and others; and oral rehydration salts. It provides specialized formulations primarily under the Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl, and Mycoderm brand names. The company also offers anti-oxidants, balanced energy drinks, and vitamins and nutraceuticals under the Enerzal, Humyl, Mum Mum 1, Prosoyal, Simyl-LBW, Simyl-MCT, and Zefrich brands. In addition, it provides various active pharmaceutical ingredients. FDC Limited was founded in 1936 and is headquartered in Mumbai, India.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms